News - Karo Bio


Current filters:

Karo Bio

Popular Filters

Karo Bio drops eprotirome and split up plans


There was a double-dose of bad news for Sweden’s Karo Bio (STO: KARO), which this week said it would…

BiotechnologyCardio-vasculareprotiromeKaro BioMergers & AcquisitionsPharmaceuticalRegulation

Karo Bio skyrockets on deal with Pfizer


Sweden’s Karo Bio (STO: KARO) saw its shares rocket 80% to 1.67 Swedish ronor on December 24, after…

Anti-Arthritics/RheumaticsImmunologicalsKaro BioLicensingNeurologicalPfizerPharmaceuticalResearch

Karo Bio to spin off preclinical development


In order to achieve better allocation of resources and competences, Swedish biotech firm Karo Bio (STO:…

BiotechnologyKaro BioMergers & AcquisitionsResearch

Back to top